Rehman Medical Institute | Pakistan
Dr. Muhammad Riaz is a distinguished microbiologist with over eleven years of progressive experience in clinical laboratory diagnostics and supervision. He earned his PhD in Microbiology from Sarhad University of Science & Information Technology, an MPhil in Medical Microbiology from the University of Peshawar, an MSc in Microbiology from the University of Karachi, and a BSc in Medical Laboratory Technology. His career has spanned roles such as Senior Laboratory Technologist, Laboratory Supervisor, and Lecturer, in which he has overseen bacterial culture, isolation, biochemical identification, antimicrobial susceptibility testing (following CLSI & EUCAST standards), molecular diagnostics (PCR), media preparation, staining, biochemical testing, and quality assurance under regulated biosafety conditions. His research has focused on antimicrobial resistance—studies include works on Salmonella Typhi, Klebsiella pneumoniae, Multidrug-Resistant Mycobacterium tuberculosis, Extensively Drug-Resistant Typhi, and Candida auris. He has participated in conferences, training workshops (e.g. ISO 15189, Infection Prevention & Control), and published multiple peer-reviewed articles; his work has accrued dozens of documents and citations in national and international journals. Dr. Riaz is also engaged in mentoring, outbreak preparedness, and diagnostic stewardship. His research interests include resistome profiling, molecular epidemiology, antimicrobial resistance surveillance, diagnostic innovation, and public health microbiology. He has received recognition for his commitment to laboratory excellence and continues to contribute to improvements in diagnostics, patient care, and infection control.
Featured Publications
Riaz, M., Ahmad, S., Sattar, F., Li, G., Din, Z. U., Ahmad, S., Azra, A., Waheed, A., Ul Haq, I., & Phelan, J. E. (2025). Whole-genome sequencing analysis of drug-resistant Salmonella Typhi in children. Pathogens, 14(10), 967.
Din, Z. U., Ullah, F., Khan, A. S., Ahmad, S., Azra, A., Waheed, A., Muhammad, N., Ali, F., Khattak, F. A., Rani, G. F., & Riaz, M. (2025). Genomic insights into pyrazinamide and fluoroquinolone resistance in multidrug-resistant tuberculosis in Khyber Pakhtunkhwa, Pakistan.International Journal of Medical Microbiology.
Khan, M., Khattak, M. T., Gul, A., Riaz, M., & Zahra, F. T. (2024). A comparable risk of extensively drug-resistant typhoid fever in the pediatric cohort during the COVID-19 pandemic. International Journal of Health Sciences.
Riaz, M., Khan, I., Khan, S., Sattar, F., & Khan, M. I. (2023). Study on multidrug, extensive drug and pan drug resistance in septicemic infants. IPS Journal of Applied Microbiology and Biotechnology, 2(1), 12.
Riaz, M. (2017). Outcome of 12-weeks triple therapy (TT), including sofosbuvir (SOF), ribavirin and pegylated interferon-alfa in all non-cirrhotic patients with chronic hepatitis-C genotype-3 infection. Medical Forum, 28(7).